{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:01:33Z","timestamp":1773158493711,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.mehy.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T21:03:13Z","timestamp":1555362193000},"page":"100-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Preclinical signs of Parkinson's disease: A possible association of Parkinson's disease with skin and hair features"],"prefix":"10.1016","volume":"127","author":[{"given":"Neringa","family":"Jucevi\u010di\u016bt\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indr\u0117","family":"Banaityt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antanas","family":"Vaitkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Balnyt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.04.013_b0005","first-page":"1","article-title":"Alpha-synuclein in Parkinson\u2019s disease: from pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.mehy.2019.04.013_b0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JPD-171203","article-title":"Simvastatin as a potential disease-modifying therapy for patients with Parkinson\u2019s disease: rationale for clinical trial, and current progress","volume":"7","author":"Carroll","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.mehy.2019.04.013_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson\u2019s disease estimated with an unbiased stereological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2019.04.013_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES recommendations for the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","article-title":"Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease","volume":"4","author":"Sulzer","year":"2018","journal-title":"NPJ Park Dis"},{"key":"10.1016\/j.mehy.2019.04.013_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cns.12493","article-title":"Position emission tomography\/single-photon emission tomography neuroimaging for detection of premotor Parkinson\u2019s disease","volume":"22","author":"Zou","year":"2016","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.mehy.2019.04.013_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mehy.2019.04.013_b0050","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1096\/fj.02-0736com","article-title":"Tyrosinase: a developmentally specific major determinant of peripheral dopamine","volume":"17","author":"Eisenhofer","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2019.04.013_b0055","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2019.04.013_b0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV damage in human skin","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.mehy.2019.04.013_b0065","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"D\u2019Orazio","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2019.04.013_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-015-0044-y","article-title":"The association between Parkinson\u2019s disease and melanoma: a systematic review and meta-analysis","volume":"4","author":"Huang","year":"2015","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.mehy.2019.04.013_b0075","doi-asserted-by":"crossref","first-page":"e45183","DOI":"10.1371\/journal.pone.0045183","article-title":"The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2019.04.013_b0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/acn3.78","article-title":"\u03b1-Synuclein inclusions in the skin of Parkinson\u2019s disease and parkinsonism","volume":"1","author":"Rodr\u00edguez-Leyva","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mdc3.12494","article-title":"The presence of alpha-synuclein in skin from melanoma and patients with Parkinson\u2019s disease","volume":"4","author":"Rodriguez-Leyva","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.mehy.2019.04.013_b0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mehy.2019.04.013_b0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.mehy.2019.04.013_b0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2006.07706.x","article-title":"The distribution of melanin in skin determined in vivo","volume":"156","author":"Matts","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2019.04.013_b0105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1468-3083.2011.04278.x","article-title":"Diversity of human hair pigmentation as studied by chemical analysis of eumelanin and pheomelanin","volume":"25","author":"Ito","year":"2011","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.mehy.2019.04.013_b0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.21535","article-title":"Genetic determinants of hair color and Parkinson\u2019s disease risk","volume":"65","author":"Gao","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0115","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.08-125435","article-title":"Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair","volume":"23","author":"Wood","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2019.04.013_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25696","article-title":"Darkening of white hair following levodopa therapy in a patient with Parkinson\u2019s disease","volume":"28","author":"Komagamine","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.mehy.2019.04.013_b0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/S0004-282X2013000200018","article-title":"Darkening of white hair in Parkinson\u2019s disease during use of levodopa rich Mucuna pruriens extract powder","volume":"71","author":"Munhoz","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.mehy.2019.04.013_b0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2230.1989.tb01992.x","article-title":"Darkening of white hair in Parkinson\u2019s disease","volume":"14","author":"Reynolds","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.mehy.2019.04.013_b0135","first-page":"87","article-title":"Racial disparities in Parkinson disease: a systematic review of the literature","volume":"05","author":"Branson","year":"2016","journal-title":"Adv Park Dis"},{"key":"10.1016\/j.mehy.2019.04.013_b0140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.22557","article-title":"Racial differences in the diagnosis of Parkinson\u2019s disease","volume":"24","author":"Dahodwala","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.mehy.2019.04.013_b0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: a population-based study of us medicare beneficiaries","volume":"34","author":"Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2019.04.013_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0531-5565(00)00210-2","article-title":"Graying: gerontobiology of the hair follicle pigmentary unit","volume":"36","author":"Tobin","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.mehy.2019.04.013_b0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2133.2012.11095.x","article-title":"Greying of the human hair: a worldwide survey, revisiting the \u201c50\u201d rule of thumb","volume":"167","author":"Panhard","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2019.04.013_b0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/BF01294730","article-title":"Is seborrhea a sign of autonomic impairment in Parkinson\u2019s disease?","volume":"104","author":"Martignoni","year":"1997","journal-title":"J Neural Transm"},{"issue":"S42","key":"10.1016\/j.mehy.2019.04.013_b0165","first-page":"001","article-title":"Seborrheic dermatitis and risk of future Parkinson\u2019s disease","volume":"78","author":"Tanner","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2019.04.013_b0170","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.64.3.320","article-title":"Spontaneous and reflex activity of facial muscles in dystonia, Parkinson\u2019s disease, and in normal subjects","volume":"64","author":"Deuschl","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2019.04.013_b0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","article-title":"The prediagnostic phase of Parkinson\u2019s disease","volume":"87","author":"Noyce","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2019.04.013_b0180","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","article-title":"Prevalence of smell loss in Parkinson\u2019s disease \u2013 a multicenter study","volume":"15","author":"Haehner","year":"2009","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.mehy.2019.04.013_b0185","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/jama.288.18.2307","article-title":"Prevalence of olfactory impairment in older adults","volume":"288","author":"Murphy","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2019.04.013_b0190","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.mehy.2019.04.013_b0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jnnp-2013-305420","article-title":"PREDICT-PD: identifying risk of Parkinson\u2019s disease in the community: methods and baseline results","volume":"85","author":"Noyce","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2019.04.013_b0205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10654-016-0130-1","article-title":"Predicting Parkinson disease in the community using a nonmotor risk score","volume":"31","author":"Darweesh","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.mehy.2019.04.013_b0210","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2019.04.013_b0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.WNL.0000103444.45882.D8","article-title":"Ophthalmologic features of Parkinson\u2019s disease","volume":"62","author":"Biousse","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2019.04.013_b0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0404.1989.tb03843.x","article-title":"Sebum secretion in idiopathic Parkinson\u2019s disease: effect of anticholinergic and dopaminergic drugs","volume":"80","author":"Villares","year":"1989","journal-title":"Acta Neurol Scand"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:07Z","timestamp":1759691767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719301707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":44,"alternative-id":["S0306987719301707"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.04.013","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical signs of Parkinson's disease: A possible association of Parkinson's disease with skin and hair features","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}